Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients

Thrombosis and Haemostasis

Volumn 93, Issue 1, 2005, Pages 76-79

  Vaitkus, Paul T ^a,g   Leizorovicz, Alain ^b   Cohen, Alexander T ^c   Turpie, Alexander G G ^d   Olsson, Carl Gustav ^e   Goldhaber, Samuel Z ^f  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITÉ LYON 1   (France)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Pharmacia   (United States)

Author keywords

Dalteparin; Deep vein thrombosis; Prevention; Proximal; Venous embolism

Indexed keywords

DALTEPARIN; PLACEBO;

ACUTE DISEASE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; HOSPITAL PATIENT; HUMAN; LEG VEIN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SYMPTOMATOLOGY; THROMBOEMBOLISM; VARICOSIS;

ACUTE DISEASE; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CLINICAL TRIALS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MORTALITY; REGRESSION ANALYSIS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; VENOUS THROMBOSIS;

EID: 12344286240     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-05-0323     Document Type: Article

References (14)

1. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001; 119(1 Suppl): 132S-75S.
2. Haas SK. Venous thromboembolic risk and its prevention in hospitalized medical patients. Semin Thromb Hemost 2002; 28: 577-84.
3. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119(1 Suppl): 176S-93S.
4. Kakkar VV, Howe CT, Flanc C, et al. Natural history of postoperative deep-vein thrombosis. Lancet 1969; 2: 230-2.
5. Meignan M, Rosso J, Gauthier H, et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med 2000; 160: 159-64.
6. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (23 Suppl 1): I22-30.
7. Moser KM, LeMoine JR. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med 1981; 94 (4 Pt 1): 439-44.
8. Monreal M, Ruiz J, Fraile M, et al. Prospective study on the usefulness of lung scan in patients with deep vein thrombosis of the lower limbs. Thromb Haemost 2001; 85: 771-4.
9. Girard P, Decousus M, Laporte S, et al. Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy. Am J Respir Crit Care Med 2001; 164: 1033-7.
10. Vaitkus PT, Leizorovicz A, Goldhaber SZ. Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study). Vasc Med 2002; 7: 269-73.
11. Leizorovicz A, Cohen AT, Turpie AGG, et al. A randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-9.
12. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338: 409-15.
13. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-9.
14. Keaton C, Julian JA, Newman TE, et al. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med 1998; 128: 663-77.